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	Parkinson’s disease (PD) is a progressive, neurodegenerative disorder that is characterized by the severe motor symptoms, including uncontrollable tremor, postural imbalance, slowness of movement and rigidity. The main pathological hallmark of PD is a pronounced loss of dopamine-producing neurons in the substantia nigra (SN), which results in a drastic decrease in dopamine in the striatum, to which these neurons project.
 
The etiology of PD has not been fully understood. Unproven hypotheses have included environmental toxins including metals, pesticides etc and genetic factors. It is proposed that a cross-talk of environmental and genetic factors may be playing a role in causing PD. A variety of mechanisms that are believed to cause accelerated cell death have also been suggested, including oxidative stress, excitotoxicity and mitochondrial dysfunction. Pathologically, PD is characterized by the loss of the pigmented dopaminergic neurons from the substantia nigra pars compacta, the presence of extracellular melanin (a dark pigment), released from degenerating neurons, reactive gliosis (increase in numbers of glial or support cells), and pink-staining cellular inclusions known as Lewy Bodies.


The exact causes and molecular pathogenesis of PD is largely undefined. However, accumulating evidence suggest the involvement of protein conformational deficit (-synuclein toxicity), metal toxicity, oxidative stress, DNA instability etc. We focused on the DNA topology and stability and -synuclein-DNA interactions in the present investigation.   

The objectives of the present investigation were:

1. To study the helicity and stability (topology) of genomic DNA isolated from selected regions 
of Parkinson disease affected human post-mortem brain (Chapter 2)


2. To study the mechanism of DNA binding and nicking property -synuclein (Chapter 3)
3. To study the conformation/aggregation of -synuclein in presence of DNA and understanding the mechanism using the chaperon property of naturally occurring osmolytes (Chapter 4)
4. To map trace elemental homeostasis in the serum samples Parkinson's patients (Chapter 5).

	The research work carried towards achieving these objectives makes the subject matter of the thesis.  The thesis is divided in to five chapters.  

Chapter 1.  General Introduction

	This chapter begins with a general account of PD, followed by an overview of current literature on symptoms, causes, disease diagnosis, treatments available and the molecular mechanism of PD pathogenesis.  The role of -synuclein in PD has been discussed in detail. The chapter also highlights the aims and scope of the present study. We also provided a hypothesis on the complexity of -synuclein toxicity in PD. 
Chapter 2.  Studies on Genomic DNA topology and stability in brain regions of Parkinson’s disease


Recently few studies showed that oxidative stress, DNA damage, chromatin condensation, and altered expression of genes are also associated with neurodegeneration in PD like Alzheimer's disease (AD). One of the consequences of redox imbalance is apoptosis and/or necrosis (programmed vs passive cell death) which are associated with neurodegeneration in PD. Studies have also shown that the levels of the nucleoside, 8-hydroxy -2’-deoxyguanosine (8-OHdG), a product of free radical attack on DNA were generally increased and differentially distributed in PD brains with highest levels in caudate, putamen, SN and cerebral cortex. Further, our laboratory evidenced that the genomic DNA undergoes a helicity change in Alzheimer’s disease (AD) from B-form to left handed Z-DNA. These observations suggest that topological changes in the genetic material may be involved in the pathogenesis of PD also. So far no studies have been reported on the DNA conformation in PD affected brain cells.

In this perspective, we studied the stability, integrity and topology of DNA isolated from five clinically and neuropathologically confirmed PD cases and six age-matched controls. Genomic DNA was isolated from eight regions in the human brain, namely frontal, temporal and occipital cortex, hippocampus, caudate/ putamen, thalamus, cerebellum and midbrain collected at post-mortem from cases of PD and controls and were analyzed for single and double strand breaks in DNA, and their conformations and topology. The results showed that DNA from midbrain in PD accumulated significant number of strand breaks than age-matched controls. Caudate nucleus/ putamen,    thalamus    and    hippocampus   also   showed   more DNA 
fragmentation compared to control brains. Circular dichroism studies showed that DNA conformation was altered with imprecise base stacking in midbrain, caudate nucleus/ putamen, thalamus and hippocampus in PD. However, DNA from frontal, temporal and occipital cortex, cerebellum was not affected significantly in PD group as compared to controls. This study provides a new data on stability, damage and conformations of DNA in different regions in brains of PD patients. 

Chapter 3.  -synuclein nicks DNA: An evidence for a new toxic role
	
The pathological hallmark of PD is the formation of insoluble protein aggregates known as Lewy bodies. The major constituent of these fibrillar structures is -synuclein, a 140 amino acid protein with a basic amino terminal and an acidic carboxy terminal. There is little information available about the neurobiology of -synuclein under normal and neurodegenerative conditions. In amyloid plaques of PD and other neurodegenerative disorders, -synuclein has cross beta conformation while it adopts -helical conformation in presence of phospholipids and lipid membranes. The formation of -helix is suggested as a protective mechanism against formation of beta sheet and aggregated structures. The major efforts of drug development are focused on the prevention or delaying of the protein aggregation and formation of plaques and recently emphasis has been given to stabilizing the non-toxic form of the protein. Recent observations showed that -synuclein is localized in the chromatin region of nuclei in the brain. Moreover, the presence of the majority of the lysine residues in the N-terminal region of -synuclein suggests a possible DNA binding role for -synuclein. 

We demonstrated in the present study, two new and novel properties of -synuclein. First, we showed that -synuclein binds to DNA and alters the conformation of DNA. Second, -synuclein was shown to have DNA nicking activity and it behaves like a nuclease enzyme. These are new evidences in literature on -synuclein binding to DNA. It was also observed that the nicking activity involves the formation of only single strand breaks. However, during long term incubations with -synuclein, double strand breaks were formed chopping the DNA into small pieces indicating that -synuclein preferentially nicks only single stranded DNA. Further, the ability of known nuclease inhibitors, Aurintricarboxylic acid (ATA) and Diethyl pyrocarbonate (DEPC) to abolish DNA nicking activity of -synuclein reveals that histidine residue at 50th position in -synuclein sequence plays a crucial role in the nicking activity. We further showed that conformational change or oligomerisation of -synuclein would enhance the nicking activity. This indicates that the oligomers of -synuclein are more toxic in terms of DNA nicking than monomers and aggregates. This work was awarded International Alzheimer’s Fellowship and was presented in the 9th International Meeting on Alzheimer’s disease and Related Disorders held in Philadelphia, USA in July, 2004.

We discussed the potential implications of the above in vitro findings to neurodegenerative changes associated with PD. We proposed that the DNA binding property of -synuclein characterized in the present study may have a significant effect on nuclear-translocated -synuclein functioning. In particular, -synuclein may interact with histone-free DNA segments and induce nicking.  

Chapter 4.  DNA induces folding in -synuclein: Understanding the mechanism using chaperon property of osmolytes

	Structurally, purified -synuclein is a natively unfolded protein. This lack of folding has been shown to correlate with the specific combinations of low overall hydrophobicity and large net charge. In vitro -synuclein readily assembles into fibrils, with morphologies and staining characteristics similar to those of fibrils extracted from PD affected brain. It has been assumed that -synuclein may exist in two structurally different isoforms in vivo: a helix-rich, membrane-bound form and a disordered, cytosolic form, with the membrane-bound -synuclein generating nuclei that seed the aggregation of the more abundant cytosolic form. 
	
In this chapter, we tried to understand the ability of different DNA to induce conformational changes in -synuclein. We have used the effect of chaperonic properties of five osmolytes viz. glycerol, betaine, taurine, TMAO, sarcosine for their ability to induce folding in -synuclein, as a model system to understand the DNA induced conformational changes in -synuclein. We provided a comprehensive picture of DNA binding effect on -synuclein fibrillation using different DNAs such as double and single stranded DNA, AT and GC sequence specific DNA, of different sizes, genomic DNA etc. We showed that only those DNA which induce a partial folding in -synuclein (GC* rich DNA) promote its aggregation, while, sscDNA forms -helix conformation in -synuclein and also inhibit aggregation to a considerable extent. It was also observed that among the osmolytes used in the present study, glycerol, TMAO, betaine and taurine induced partial folding in -synuclein and enhanced the fibrillation kinetics. 

The ability of DNA and osmolytes in inducing conformational transition in -synuclein, indicates that two factors are critical in modulating -synuclein folding: (i) Electrostatic interaction as in the case of DNA, and (ii) Hydrophobic interactions as in the case of osmolytes.  We feel that the property of sscDNA in inducing -helical conformation in -synuclein and inhibiting the fibrillation may be of significance in engineering DNA-chip based therapeutic approaches to PD and other amyloid disorders. Further, from the fact that other amyloidogenic peptides like Aβ, tau and prions also have DNA binding property, it appears that the DNA binding is a unifying property of amyloidogenic peptides implicated in various neurodegenerative disorders. 

Chapter 5. Serum trace elemental levels and the complexity of inter-elemental relationships in patients with PD 

Metals are well established to be risk factors for PD, though the significance of metals in the aetiopathogenesis of PD is still unknown. Several studies have shown decreased copper, increased zinc and iron in the substantia nigra and increased copper concentrations in the cerebrospinal fluid of PD affected patients. Though much work has been done on metal homeostasis in PD brain, limited data is available on trace elemental levels and their inter-relationships in serum samples of Parkinson's patients. Moreover, most of the available information is limited to few selected elements and there is no study, which examines inter-elemental relationships with regard to severity of PD. The aim of this study was to assess the serum levels of 12 elements (Na, K, Fe, Al, Cu, Zn, Ca, Mg, Mn, Si, P and S) in patients with early and severe PD compared with a control population and also to understand the possible relevance of inter-elemental relationships to the progression of PD.

The results showed a definite pattern of variation among certain elements in early and severe PD compared to control. In both early and severe PD serum, Al and S (p<0.05) were decreased compared to control. Fe (p<0.01) and Zn (p<0.05) were significantly low in severe PD, while K, Mg, Cu (p<0.01) and P (p<0.05) were high in early and severe PD compared to control. The data revealed a clear imbalance in the elemental interrelationship in both early and severe PD serum compared to control as shown by the direct and inverse correlations. These results suggested that a definite disturbance in the elemental homeostasis occurs during the progression of PD. There has been a controversy regarding metal levels in PD serum and also possible role of metals as risk factors for PD. It is not clear whether alteration in metal homeostasis is a cause or consequence of disease pathology. So far, there is no detailed or comprehensive database on metal homeostasis and inter-relationships. The available reports only indicated the changes in levels of one or two individual elements, but fall short to correlate the element-to-element inter-relationship pattern with the disease progression. In this perspective, the present study provided a comprehensive database on concentrations of as many as 12 elements (majority of essential and few important toxic elements) in PD serum in comparison with control groups.

	We further advocated from the above results that irrespective of metals being primary risk factors or consequences of disease mechanism, a moderate change in a single metal ion will upset the whole elemental homeostasis pool resulting in the significant imbalance in elemental levels in the body system (serum, CSF and brain). The effect of increase or decrease of a single metal is not restricted to the presenting metal alone, it will affect the total elemental and charge distribution pattern in the system.

	 The thesis ends with a comprehensive Summary and Conclusions of the present study.

In a nut shell the study provides the following significant contributions

1.	The study provided a new data on DNA stability, integrity and topology of genomic DNA isolated from eight different brain regions from PD affected human brain samples (Chapter 2).

2.	We evidenced two new and novel properties of -synuclein: i) DNA binding and ii) DNA nicking. We showed that -synuclein behaves as an endonuclease. These have been very intriguing observations which exposed a new toxic role of -synuclein. The observations lead to a new debate on whether direct -synuclein induced DNA damage has any role to play in DNA fragmentation observed in PD brain and hence open new avenues of research in this direction (Chapter 3).

3.	 We showed that single stranded circular DNA induces a stable, aggregation resistant, -helical conformation in natively random-coil -synuclein. This observation is very important in investigating the possibility of using DNA-chip based therapy for PD. We also showed that GC* rich DNA forms a partially folded intermediate conformation in -synuclein and this conformation has high aggregation propensity. Using chaperonic properties of -synuclein as model system we showed that increase in hydrophobicity and decrease in the net charge are critical in -synuclein conformational transition and fibrillation (Chapter 4).

4.	We generated a comprehensive database on the levels of 12 elements (both essential and toxic) in serum samples of PD affected patients and showed that there is a definite disturbance in inter-element homeostasis pattern in PD serum (Chapter 5).  
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